Advertisement Continue reading the main story Supported by Continue reading the main story Outcry Forces UnitedHealthcare to Delay Plan to Deny Coverage for Some E.R. Visits Within days of announcing a policy shift aimed at cutting back on reimbursements for emergency room care, the major insurer retreated — for now. Though the Covid-19 crisis has… Read More »
After snagging the first Japanese CAR-T approval in March, Novartis has won the go-ahead to sell its groundbreaking med, Kymriah, under the country’s national insurance system. And that gives the brand a chance to boost lagging sales. The Central Social Insurance Medical Council of Japan’s Ministry of Health, Labor and Welfare has approved coverage of… Read More »
October 22, 2018 Posted By Categories Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @KLomangino. Here’s another example in our occasional series documenting how the New York Times’ ‘Well’ section is often unwell. This time it’s a brief story claiming that “Coffee may tame the redness of rosacea.” Let’s start with the… Read More »